Stockreport

Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia [Financial Post (Toronto, Ontario, Canada)]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of centra [Read more]